31 January 2022
Nuformix plc
("Nuformix" or the "the Company")
Director/PDMR Shareholding
Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces that it has granted a total of 3,000,000 warrants each to Dr Alastair Riddell, Dr Julian Gilbert and Maddy Kennedy with an exercise price of 1.45p per share.
- Ends -
Enquiries:
|
Nuformix plc |
via Walbrook |
||||
|
Dr Alastair Riddell, Executive Chairman |
|||||
|
Allenby Capital Limited |
+44 (0) 20 3328 5656 |
||||
|
Nick Athanas / George Payne (Corporate Finance) |
|||||
|
Stefano Aquilino / Matt Butlin (Sales and Corporate Broking) |
|||||
|
Walbrook PR |
nuformix@walbrookpr.com or +44 (0)20 7933 8780 |
||||
|
Anna Dunphy / Phillip Marriage |
Tel: +44 (0)7876 741 001 / +44 (0)7867 984 082 |
||||
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Dr Alastair Riddell |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
PDMR - Executive Chairman |
||||
|
b) |
Initial notification /Amendment |
Initial notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Nuformix plc |
||||
|
b) |
LEI |
2138003XG3H3I2J3BJ24 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Warrants to acquire ordinary shares at a price of 1.45p per share. GB00BYW79Y38 |
||||
|
b) |
Nature of the transaction |
Granting of warrants |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information |
Single Transaction |
||||
|
e) |
Date of the transaction |
31 January 2022 |
||||
|
f) |
Place of the transaction |
Off-market transaction |
||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Dr Julian Gilbert |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
PDMR - Non-executive Director |
||||
|
b) |
Initial notification /Amendment |
Initial notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Nuformix plc |
||||
|
b) |
LEI |
2138003XG3H3I2J3BJ24 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Warrants to acquire ordinary shares at a price of 1.45p per share. GB00BYW79Y38 |
||||
|
b) |
Nature of the transaction |
Issue of warrants |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information |
Single Transaction |
||||
|
e) |
Date of the transaction |
31 January 2022 |
||||
|
f) |
Place of the transaction |
Off-market transaction |
||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Maddy Kennedy |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
PDMR - Non-executive Director |
||||
|
b) |
Initial notification /Amendment |
Initial notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Nuformix plc |
||||
|
b) |
LEI |
2138003XG3H3I2J3BJ24 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Warrants to acquire ordinary shares at a price of 1.45p per share. GB00BYW79Y38 |
||||
|
b) |
Nature of the transaction |
Issue of Warrants |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information |
Single Transaction |
||||
|
e) |
Date of the transaction |
31 January 2022 |
||||
|
f) |
Place of the transaction |
Off-market transaction |
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.